http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000034300-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c8d4dc7bd1a30d8fda907fceaeb4e69 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate | 1998-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6379ca254f0bda8af65d6942b25e743 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_755037a7386c464423f40bf736c8b858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97556446fa1253812c78ba6458c26496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5508f313e5c0bbd32b29cb47628cb5e |
publicationDate | 2000-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2000034300-A |
titleOfInvention | Anti-phosphorylated tau protein antibody and method for detecting Alzheimer's disease using the same |
abstract | (57) [Problem] To provide a method for detecting Alzheimer's disease which is more specific for Alzheimer's disease. A partial peptide of a phosphorylated tau protein in a paired helical filament, comprising a serine residue at position 199 in the amino acid sequence represented by SEQ ID NO: 1 in the sequence listing, wherein the serine residue is A peptide having a phosphorylated peptide, a threonine residue at position 231, a peptide having a phosphorylated threonine residue, a peptide having a serine residue at position 235, and a peptide having a phosphorylated serine residue; and Threonine residue at position 231, 2 The phosphorylated tau protein containing a serine residue at position 35, obtained as an immunogen a partial peptide selected from a peptide in which the threonine residue and the serine residue are phosphorylated, and specifically binding to the partial peptide Is detected by examining the reactivity between an antibody against and a sample obtained from an individual suspected of having Alzheimer's disease. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019027952-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0250121-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114617-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7888050-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006225396-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7029718-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11150252-B2 |
priorityDate | 1998-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 291.